European Federation of Medicinal Chemistry

What European Federation of Medicinal Chemistry does

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) is an independent, non-profit scientific association founded on December 19, 1969, and headquartered in Bern, Switzerland. It represents 31 national adhering organizations across 26 European countries and approximately 9,000 medicinal chemists and chemical biologists, serving as the premier pan-European umbrella body for the discipline. EFMC is governed by a 7-member Executive Committee elected by a Council of delegates from national member societies, and it is funded through corporate membership fees, event revenues, award sponsorships, and journal partnerships rather than equity capital.

EFMC's product portfolio is service-based and event-driven rather than technology-based. Core offerings include four flagship symposia — the biennial EFMC-ISMC (~1,200 delegates), EFMC-ASMC, the joint EFMC-ACSMEDI Medicinal Chemistry Frontiers symposium (with the American Chemical Society), and the annual EFMC-YMCS — supplemented by short courses, certified schools (e.g., ESMEC, Swiss Course on Medicinal Chemistry), the Young Scientists Network (EFMC-YSN) with its MedChemBioOnline webinars and mentoring program, official journal partnerships with ChemMedChem and ChemBioChem (Wiley, effective April 2022), a portfolio of ten awards and prizes, a Best Practices knowledge initiative, and a job portal. The underlying "technology" is a community orchestration and curation layer: scientific programming, certification standards, peer recognition, and digital content channels (newsletters, interview series, webinars) rather than proprietary software or AI systems.

EFMC's revenue model is a hybrid of subscription (corporate memberships at €2,250–€8,000 per year, with three-year packages), one-time event registration fees, journal licensing/partnership royalties, and sponsored awards. Corporate members include AbbVie, AstraZeneca, Novartis, Roche, GSK, Johnson & Johnson, Merck, Boehringer Ingelheim, and Eli Lilly alongside biotech and CRO firms. Geographic reach is pan-European with formal international linkages to ACS, EuCheMS, EUFEPS, ICBS, CPA, AFMC, IUPAC, and the Brazilian Chemical Society, supporting cross-continental collaboration in drug discovery and chemical biology.

Name

European Federation of Medicinal Chemistry

Legal name

European Federation for Medicinal Chemistry and Chemical Biology

Website

https://efmc.info

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

EFMC is a Switzerland-based non-profit scientific federation founded in 1969, representing 31 national medicinal chemistry societies across 26 European countries and over 9,000 scientists. It runs flagship biennial symposia, an awards portfolio, journal partnerships, and a Young Scientists Network, funded by corporate memberships and event fees.

Ownership category

akta.pro rank

Product category

Professional Scientific Federation Services

NAICS

Colleges, Universities, and Professional Schools (611310), Business Schools and Computer and Management Training (6114)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAGABAG

Medicine & Allied Health (Clinical)

Education/Educational Publishing & Learning Content/Higher Education Textbooks & Courseware

SECONDARYEDAGAJAB

Open Courseware & Course Modules (OCW)

Education/Educational Publishing & Learning Content/Open Educational Resources (OER) & Open Textbooks

Keywords

• Medicinal chemistry events
• Scientific symposiums
• Professional federation services
• Chemical biology conferences
• Young scientists network

Headquarters

HQ city

Louvain-la-neuve

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Corporate Membership Fees: Pharmaceutical and biotech companies pay annual membership fees to become corporate members. Standard Corporate Membership is 2,250€ per year, with three-year packages at 6,000€. Extended packages supporting the Young Scientists Network cost 3,000€ annually or 8,000€ for three years.
2. Event Registration Fees: Revenue generated from registration fees for major symposia including EFMC-ISMC, EFMC-ASMC, EFMC-ACSMEDI Medicinal Chemistry Frontiers, EFMC-YMCS, short courses, and certified schools. The biennial ISMC typically attracts around 1,200 delegates.
3. Journal Partnership: Partnership with ChemMedChem and ChemBioChem as official EFMC journals since April 2022. These Wiley-published journals serve as publication platforms for the medicinal chemistry community.
4. Awards & Prizes Sponsorship: Organizations sponsor EFMC awards including Nauta Foundation (Nauta Pharmacochemistry Award), Prous Institute (Overton and Meyer Award), UCB (Ehrlich Award), WuXi AppTec (Chemical Biology Award), and Selvita (YSN PhD Prize).

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

EFMC is an independent, non-profit scientific federation that organizes and delivers international symposia (EFMC-ISMC, EFMC-ASMC, EFMC-ACSMEDI Medicinal Chemistry Frontiers, EFMC-YMCS), short courses, certified schools, webinars (MedChemBioOnline, EFMC² Tandem Talks), awards and prizes, and corporate membership programs for the European medicinal chemistry and chemical biology community. It also runs the Young Scientists Network (EFMC-YSN) providing mentoring, training courses, and grants, and partners with Wiley to publish official journals ChemMedChem and ChemBioChem.

Product overview

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) is an independent scientific association that does not offer a unified software product but provides a portfolio of event-based services, educational programs, and networking initiatives for the medicinal chemistry and chemical biology community. The core offerings include major international symposium series (EFMC-ISMC, EFMC-ASMC, EFMC-ACSMEDI Medicinal Chemistry Frontiers), the annual Young Medicinal Chemists' Symposium, and short courses on specialized topics. Supporting programs include the Young Scientists Network with webinars (MedChemBioOnline, EFMC² Tandem Talks), awards and prizes recognizing excellence, certified schools meeting EFMC standards, official journals (ChemMedChem, ChemBioChem), best practices documentation, corporate membership, and a job portal for the community. These services operate independently rather than as an integrated platform.

Differentiator

Problem solved

Functional benefit

Products and services

• EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC)

Quantifiable outcome

• 55+ years of advancing medicinal chemistry in Europe since founding on December 19, 1969
• +3 more outcomes

Named customers14 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered flagship, core and regional.

• ChemMedChem (Wiley)flagshipStrategic or Co-development Partner · 5 April 2022Partnership agreement making ChemMedChem an official EFMC journal since April 5, 2022. Published by Wiley, it serves as a platform for the European medicinal chemistry community.
• ChemBioChem (Wiley)flagshipStrategic or Co-development Partner · 5 April 2022Partnership agreement making ChemBioChem an official EFMC journal since April 5, 2022. Published by Wiley, it serves as a platform for chemical biology research.
• ACS Division of Medicinal ChemistrycoreStrategic or Co-development PartnerStrong link with the Medicinal Chemistry Division of the American Chemical Society, providing international collaboration and joint events including the EFMC-ACSMEDI Medicinal Chemistry Frontiers symposia.
• European Federation for Pharmaceutical Sciences (EUFEPS)coreStrategic or Co-development PartnerStrong institutional link with EUFEPS for collaboration on pharmaceutical sciences across Europe.
• European Chemical Society (EuCheMS)coreStrategic or Co-development PartnerStrong link with EuCheMS for collaboration on chemical sciences at the European level.
• International Chemical Biology Society (ICBS)coreStrategic or Co-development PartnerStrong international partnership with ICBS for global chemical biology community engagement.
• Chinese Pharmaceutical Association (CPA)regionalStrategic or Co-development PartnerInternational partnership with CPA extending EFMC's reach to the Asian pharmaceutical community.
• Asian Federation of Medicinal Chemistry (AFMC)regionalStrategic or Co-development PartnerPartnership with AFMC providing broad international footprint across Asia in medicinal chemistry.
• IUPAC (International Union of Pure and Applied Chemistry)coreStrategic or Co-development PartnerOfficial link with IUPAC for international standards and recognition in chemistry, including the IUPAC-Richter Prize.
• Brazilian Chemical Society - Medicinal Chemistry DivisionregionalStrategic or Co-development PartnerPartnership extending EFMC's reach to Latin America through the Brazilian medicinal chemistry community.
• Swiss Chemical Society (SCS)coreStrategic or Co-development PartnerCo-organiser of EFMC-ISMC 2026 in Basel and the International Symposium on Chemical Biology (EFMC-ISCB).

Scale indicators4 records

Direct peers

• European Chemical Society (EuCheMS): EuCheMS is the umbrella European chemical sciences organisation and a direct peer/partner to EFMC, representing chemistry societies across Europe with overlapping scope in education, events, and policy advocacy.
• European Federation for Pharmaceutical Sciences (EUFEPS): EUFEPS is a strategic EFMC partner and direct peer, a European federation serving pharmaceutical sciences audiences with events, education, and policy engagement that intersects with EFMC's medicinal chemistry focus.
• ACS Division of Medicinal Chemistry (ACS MEDI): American Chemical Society's Medicinal Chemistry Division is EFMC's closest direct counterpart, organising parallel symposia (e.g., the joint EFMC-ACSMEDI Medicinal Chemistry Frontiers) and awards for medicinal chemists, with an overlapping academic/industry audience and sponsor base.
• Asian Federation of Medicinal Chemistry (AFMC): AFMC is EFMC's regional mirror in Asia, running parallel medicinal chemistry symposia, awards, and country-membership structures aimed at the same scientific community across a different geography.
• International Chemical Biology Society (ICBS): ICBS is a global society focused on chemical biology — EFMC's co-equal discipline — and a strategic partner with overlapping goals of advancing chemical-biology research, conferences, and recognition.

Broad incumbents

• American Chemical Society (ACS): The ACS is the largest global chemistry society and operates ACS MEDI as well as broad publishing, education, and meeting portfolios (national meetings, JACS) that compete for the same medicinal chemistry audience, sponsors, and authors.
• American Association of Pharmaceutical Scientists (AAPS): AAPS is a US-based broader pharmaceutical sciences society running annual meetings, journals, and awards that compete for pharmaceutical industry sponsors and medicinal chemistry/sciences attendees.
• Royal Society of Chemistry: The RSC is the UK's chartered body for chemical sciences and a broader incumbent that also runs medicinal-chemistry-relevant events, publications (e.g., MedChemComm/ChemComm), education, and corporate membership programs serving an overlapping community.
• IUPAC (International Union of Pure and Applied Chemistry): IUPAC is the global chemistry standards body and an EFMC partner running international prizes (IUPAC-Richter), congresses, and nomenclature work that overlaps with EFMC's recognition and standards-setting activities.

Regional players

• Chinese Pharmaceutical Association (CPA): CPA is the principal Chinese professional society for pharmaceutical sciences and an EFMC partner, hosting national and Asia-Pacific medicinal chemistry events that overlap in scope but operate primarily within China.

Market position

Strengths5 records

Weaknesses5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/euromedchem
• Facebookfacebook.com/europeanfederationformedicinalchemistry
• LinkedInlinkedin.com/company/efmc---european-federation-for-medicinal-chemistry

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Federation of Medicinal Chemistry